Kanako Izumi‐Nagai

Suppression of Diabetes-Induced Retinal Inflammation by Blocking the Angiotensin II Type 1 Receptor or Its Downstream Nuclear Factor-κB Pathway

Norihiro Nagai, Kanako Izumi‐Nagai, Yuichi Oike et al. · Investigative Ophthalmology & Visual Science · 2007 · 184 citations

Life Sciences, Molecular Biology, Ophthalmology +17

Macular Pigment Lutein Is Antiinflammatory in Preventing Choroidal Neovascularization

Kanako Izumi‐Nagai, Norihiro Nagai, Kazuhiro Ohgami et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2007 · 158 citations · Full text

Medicine, Ophthalmology, Vision Science +17

Interleukin-6 Receptor-Mediated Activation of Signal Transducer and Activator of Transcription-3 (STAT3) Promotes Choroidal Neovascularization

Kanako Izumi‐Nagai, Norihiro Nagai, Yoko Ozawa et al. · American Journal Of Pathology · 2007 · 150 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Angiotensin II Type 1 Receptor–Mediated Inflammation Is Required for Choroidal Neovascularization

Norihiro Nagai, Yuichi Oike, Kanako Izumi‐Nagai et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2006 · 119 citations · Full text

Medicine, Ophthalmology, Pathobiology +17

Predictive factors for non-response to intravitreal ranibizumab treatment in age-related macular degeneration

Misa Suzuki, Norihiro Nagai, Kanako Izumi‐Nagai et al. · British Journal of Ophthalmology · 2014 · 98 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17